Mei Jiang

机构：Guangzhou University of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Central South University, Hunan University of Traditional Chinese Medicine, King's College London, Chengdu Sport University, Chengdu Institute of Information Technology (China), First Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen Bao'an District People's Hospital, State Key Laboratory of Respiratory Disease, Guangzhou Medical University · ORCID：0000-0002-7393-2664

发表论文 177 篇 · 总被引 4937 次 · h-index 32

代表论文

• Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke (2024 · New England Journal of Medicine · 被引 173)
• Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma (2024 · JAMA Oncology · 被引 68)
• Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs (2025 · Nature Immunology · 被引 39)
• Application of image recognition technology in pathological diagnosis of blood smears (2024 · Clinical and Experimental Medicine · 被引 21)
• Exploring the potential mechanism of ginsenoside Rg1 to regulate ferroptosis in Alzheimer's disease based on network pharmacology (2024 · European Journal of Pharmacology · 被引 9)
• Slow-release ferrous effects on synchronous stabilization of lead, cadmium, and arsenic in soil (2025 · Environmental Geochemistry and Health · 被引 8)